ralmitaront , CAS No.2133417-13-5, Agonist of TA 1 receptor

Item Number
R613090
Grouped product items
SKUSizeAvailabilityPrice Qty
R613090-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$271.90
R613090-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$948.90
View related series
TA1 receptor Agonist

Basic Description

Synonyms(s)-5-ethyl-4-methyl-n-(4-(morpholin-2-yl)phenyl)-1h-pyrazole-3-carboxamide | 5-Ethyl-4-methyl-N-{4-[(2S)-morpholin-2-yl]phenyl}-1H-pyrazole-3-carboxamide | 5-Ethyl-4-methyl-N-[4-[(2S)-morpholin-2-yl]phenyl]-1H-pyrazole-3-carboxamide | DTXSID901336976 | 1
Specifications & PurityMoligand™
GradeMoligand™
Action TypeAGONIST
Mechanism of actionAgonist of TA 1 receptor

Associated Targets(Human)

TAAR1 Tclin Trace amine-associated receptor 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 5-ethyl-4-methyl-N-[4-[(2S)-morpholin-2-yl]phenyl]-1H-pyrazole-3-carboxamide
INCHI InChI=1S/C17H22N4O2/c1-3-14-11(2)16(21-20-14)17(22)19-13-6-4-12(5-7-13)15-10-18-8-9-23-15/h4-7,15,18H,3,8-10H2,1-2H3,(H,19,22)(H,20,21)/t15-/m1/s1
InChi Key XHHXGKRFUPEPFM-OAHLLOKOSA-N
Canonical SMILES CCC1=C(C(=NN1)C(=O)NC2=CC=C(C=C2)C3CNCCO3)C
Isomeric SMILES CCC1=C(C(=NN1)C(=O)NC2=CC=C(C=C2)[C@H]3CNCCO3)C
Alternate CAS 2133417-13-5
PubChem CID 130429734

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Dedic N, Dworak H, Zeni C, Rutigliano G, Howes OD.  (2021)  Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies..  Int J Mol Sci,  22  (24): (1755-70).  [PMID:34947997] [10.1021/op500134e]
2. Sparacino G, Verdolini N, Vieta E, Pacchiarotti I.  (2022)  Existing and emerging pharmacological approaches to the treatment of mania: A critical overview..  Transl Psychiatry,  12  (1): (169).  [PMID:35461339] [10.1021/op500134e]
3. Kantrowitz JT.  (2021)  Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions..  CNS Drugs,  35  (11): (1153-1161).  [PMID:34655036] [10.1021/op500134e]
4. Kane JM.  (2022)  A New Treatment Paradigm: Targeting Trace Amine-Associated Receptor 1 (TAAR1) in Schizophrenia..  J Clin Psychopharmacol,  42  (5 Suppl 1): (S1-S13).  [PMID:36099402] [10.1021/op500134e]

Solution Calculators